Mode
Text Size
Log in / Sign up

Alcoholic Liver Disease

Part of Alcohol-Induced Disorders

6 published articles · Updated continuously

Clinical Trial Landscape

Clinical Trials for Alcoholic Liver Disease

3 trials tracked for Alcoholic Liver Disease: 2 in phase 3 or 4.

3Trials tracked
2Phase 3 & 4
0Recruiting
0With published results
Phase distribution
Phase 4 1 Phase 3 1 Phase 2 1
  1. Phase 4 Effect of Probiotics on Gut-Liver Axis of Alcoholic Liver Disease Completed
  2. Phase 3 Effects of SAMe in Patients With Alcoholic Liver Disease Completed
  3. Phase 2 Acamprosate Safe to Use in Individuals With Liver Disease. Completed

Showing the 3 most-cited and recently-updated of 3 trials. Browse the full registry →

Trial data sourced from ClinicalTrials.gov. Counts describe the research landscape and are not a treatment recommendation. Informational only — not medical advice.

HCP Mode — summaries include clinical detail, trial data, and statistical outcomes.
Patient Mode — summaries use plain language, avoiding clinical jargon.

Questions about Alcoholic Liver Disease

Can phytochemicals show protective effects in models of Alcoholic Liver Disease?

Yes, multiple phytochemicals from plants like Schisandra chinensis, oysters, and Artemisia stechmanniana show protective effects in animal models of alcoholic liver disease by reducing oxidative stress, inflammation, and liver damage.

Full answer →
Does the aMAP risk score predict mortality for patients with Alcoholic Liver Disease?

The aMAP risk score is associated with increased mortality in patients with alcohol-related liver disease.

Full answer →